2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 96.109 | 94.075 | 100.018 | 94.324 | 99.835 | 87.057 | 47.964 | 104.128 | 73.303 | 26.921 |
Total Income - EUR | 96.175 | 94.866 | 124.052 | 94.331 | 99.835 | 89.754 | 51.758 | 105.363 | 73.303 | 27.944 |
Total Expenses - EUR | 93.715 | 79.369 | 111.830 | 87.253 | 89.245 | 86.315 | 68.469 | 94.728 | 69.296 | 45.725 |
Gross Profit/Loss - EUR | 2.461 | 15.497 | 12.222 | 7.078 | 10.591 | 3.439 | -16.712 | 10.635 | 4.008 | -17.781 |
Net Profit/Loss - EUR | 2.461 | 12.373 | 11.264 | 2.926 | 9.592 | 2.544 | -17.191 | 9.619 | 3.289 | -18.050 |
Employees | 5 | 7 | 6 | 6 | 4 | 3 | 4 | 3 | 2 | 1 |
Check the financial reports for the company - Humanamed Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 69.795 | 65.419 | 48.957 | 77.629 | 71.451 | 64.341 | 56.963 | 54.487 | 47.507 | 41.505 |
Current Assets | 7.251 | 23.253 | 49.012 | 60.664 | 73.637 | 54.101 | 25.057 | 19.487 | 24.554 | 111.358 |
Inventories | 2.818 | 7.184 | 11.500 | 16.972 | 19.724 | 25.814 | 20.324 | 6.735 | 0 | 0 |
Receivables | 1.428 | 1.634 | 34.706 | 42.531 | 53.219 | 27.577 | 2.726 | 8.683 | 22.904 | 109.851 |
Cash | 3.006 | 14.435 | 2.806 | 1.161 | 694 | 710 | 2.008 | 4.069 | 1.651 | 1.507 |
Shareholders Funds | -7.434 | 4.876 | 16.091 | 14.964 | 21.839 | 14.602 | -5.237 | 4.498 | 7.802 | -10.272 |
Social Capital | 11.200 | 11.294 | 11.178 | 10.989 | 10.788 | 10.579 | 10.378 | 10.148 | 10.179 | 10.149 |
Debts | 84.508 | 83.824 | 81.878 | 123.329 | 123.249 | 108.499 | 87.257 | 69.475 | 66.834 | 163.135 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8690 - 8690" | |||||||||
CAEN Financial Year |
8690
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Humanamed Srl